Boryeong has entered the Korean children’s over‑the‑counter (OTC) digestive and antacid market, estimated at roughly 10 billion KRW. The market is currently dominated by GC녹십자’s Baekcho Syrup Plus, which accounts for about 70% of sales, followed by Dong‑A Pharmaceutical’s Benachio Kids Liquid and Donghwa Pharmaceutical’s Komahwalmyung Water.
Boryeong’s subsidiary, Boryeong Consumer Healthcare, recently launched a new product called "Malkuncho Kids Syrup" and is actively working to expand its presence in pharmacy channels. According to IQVIA, the market size for children’s digestive and antacid products is projected to reach 9.62 billion KRW by May 2026 (MAT basis).
Market AnalysisSep 9, 2026•3 min read
Boryeong launches "Malkuncho Kids Syrup" to enter 10 billion KRW children's digestive OTC market
Boryeong Consumer Healthcare rolls out "Malkuncho Kids Syrup" aiming at Korea's ~10 billion KRW children’s digestive and antacid market, where GC녹십자 holds ~70% share.
Compiled by the Pharmacountry team · Source: KPA News
Topics:
Ratings
(0)
(0)
(0)
(0)
(0)
Leave your rating